The AVYIA Journal

All Articles · Page 5

The latest ketamine research explained in plain language, real patient case studies, and practical guides for your mental health.

Page 5 of 7

Explore esketamine, psilocybin, and pramipexole as emerging treatments for depression unresponsive to traditional antidepressants.

A single 0.5 mg/kg ketamine infusion rapidly relieves depression and suicidality in patients with treatment-resistant double depression.

Ketamine reduces subgenual cingulate cortex hyperactivity, easing anhedonia in major depression with fast, targeted neural effects.

Ketamine improves depression in PTSD-resistant veterans, with rapid, dose-dependent effects but limited impact on core PTSD symptoms.

Boost energy, focus, and performance with these science-backed nutrition tips designed for high-performing, time-strapped professionals.

Explore how very low dose sublingual ketamine improves mood, cognition, and sleep in treatment-resistant unipolar and bipolar depression.

Explore how Ketamine Assisted Psychotherapy (KAP) improves depression, anxiety, and PTSD in real-world clinical settings.

Study explores ketamine’s antidepressant effects in veterans with PTSD, highlighting dose, safety, and clinical implications.

Explore the full benefits of NAD+ IV therapy for aging, energy, brain function, and metabolism—all backed by modern science.

Discover science-based strategies to support healthy aging, from diet and sleep to hormones, stress, and brain health.

Learn what causes hangovers, how to treat them, and the health risks of repeated episodes. Expert-backed tips for fast, effective relief.

Stars like Elon Musk and Amanda Feilding are reshaping how we view psychedelics—from stigma to science, safety, and mental health.